| Trial ID: | L6931 |
| Source ID: | NCT00670683
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Observational Study of Patients With Diabetes Using Levemir® FlexPen®
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Incidence of adverse events, for the duration of the trial | Secondary: Weight, for the duration of the trial|FBG (Fasting Blood Glucose), for the duration of the trial|2hr-PPBG (2hr-Post Prandial Blood Glucose), for the duration of the trial|HbA1c, for the duration of the trial|Adverse events, for the duration of the trial|Clinical laboratory abnormality, for the duration of the trial
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
797
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2007-07
|
| Completion Date: |
2009-09
|
| Results First Posted: |
|
| Last Update Posted: |
2016-03-03
|
| Locations: |
Pusan, 602-739, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00670683
|
